UnitedHealth Group’s (UNH) “Overweight” Rating Reiterated at KeyCorp

KeyCorp reiterated their overweight rating on shares of UnitedHealth Group (NYSE:UNH) in a report released on Friday,Benzinga reports. The brokerage currently has a $650.00 price objective on the healthcare conglomerate’s stock.

A number of other analysts have also recently commented on UNH. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. TD Cowen raised their target price on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday. Two investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus target price of $627.74.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE:UNH opened at $510.03 on Friday. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $630.73. The stock’s fifty day moving average price is $549.37 and its 200-day moving average price is $563.18. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. The company has a market cap of $469.38 billion, a P/E ratio of 33.23, a PEG ratio of 1.42 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the company earned $5.83 earnings per share. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.19%.

Institutional Investors Weigh In On UnitedHealth Group

Hedge funds have recently bought and sold shares of the business. Delta Financial Group Inc. lifted its holdings in shares of UnitedHealth Group by 1.0% in the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after purchasing an additional 17 shares in the last quarter. First PREMIER Bank lifted its stake in UnitedHealth Group by 7.0% in the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after acquiring an additional 18 shares in the last quarter. Genesee Capital Advisors LLC increased its holdings in shares of UnitedHealth Group by 1.9% in the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after purchasing an additional 18 shares during the period. Jmac Enterprises LLC boosted its holdings in shares of UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after purchasing an additional 18 shares during the period. Finally, Matrix Private Capital Group LLC increased its stake in UnitedHealth Group by 3.6% in the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after buying an additional 19 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.